| LONZA N |
| Date/Time | / |
| Chg. / Chg.(%) | - / |
| Bid | - |
| Ask | - |
| Open | - |
| Previous Close | - |
| High | - |
| Low | - |
| Volume [CHF] | - |
| Volume [Units] | |
| Price fixings | |
| ISIN | CH0013841017 |
| Security | LONN |
| Exchange | SIX Swiss Exchange |
| Type | Stock |
Other Exchanges
| Exchange | Last | Volume | |
|---|---|---|---|
| Lang & Schwa.. | 502.600 |  |
|
| SIX Swiss Ex.. | 558.40 | |
247,007 |
| London Inter.. | 557.19 | |
18,048 |
| Cboe Europe .. | 557.20 |  |
16,906 |
| Cboe Europe .. | 557.40 | |
11,136 |
| Turquoise | 556.60 | |
3,584 |
| Nasdaq Other.. | 611.0400 | |
247 |
| Mexico | 12,110.20 | |
360 |
| TradeGate | 294.000 | 298 | |
| Frankfurt | 293.9000 | 63 | |
| Düsseldorf | 291.20 | 0 | |
| München | 291.30 | 0 | |
| Berlin | 296.90 | 0 | |
| Hamburg | 291.30 | 0 | |
| gettex | 296.100 | ||
| Singapore | 79.97 | 500 | |
| EUREX | Options | ||
News
- aTyr Pharma and Lonza Announce Manufacturing Agreement for aTyr’s Anti-NRP2 Antibody ATYR2810
04/14/2021 / 14:00 - GlobeNewswire - Arbor Biotechnologies Names Devyn Smith, Ph.D., as CEO
04/01/2021 / 14:00 - GlobeNewswire - Altimmune Expands AdCOVID™ Manufacturing Collaboration with Lonza
03/12/2021 / 07:00 - GlobeNewswire - Arbor Biotechnologies Names Mark D. Angelino to its Board of Directors
03/03/2021 / 14:00 - GlobeNewswire - Capricor Collaborates with Lonza for the Development of CAP-1002, its Cell Therapy Candidate for the Treatment of Duchenne Muscular Dystrophy and Other Indications
01/12/2021 / 15:05 - GlobeNewswire
Real-time